Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.661
AS - Asia 8.155
EU - Europa 8.097
SA - Sud America 1.070
AF - Africa 154
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 17
Totale 31.186
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.241
SG - Singapore 2.383
IT - Italia 2.260
CN - Cina 1.970
VN - Vietnam 1.691
DE - Germania 1.298
RU - Federazione Russa 1.076
HK - Hong Kong 942
BR - Brasile 858
SE - Svezia 811
IE - Irlanda 576
GB - Regno Unito 457
UA - Ucraina 361
CA - Canada 325
IN - India 285
FI - Finlandia 234
FR - Francia 189
ID - Indonesia 168
AT - Austria 149
PL - Polonia 146
KR - Corea 136
DK - Danimarca 116
JP - Giappone 94
NL - Olanda 93
AR - Argentina 85
ZA - Sudafrica 81
TR - Turchia 80
ES - Italia 74
BD - Bangladesh 68
MX - Messico 65
BE - Belgio 54
IR - Iran 53
IQ - Iraq 45
TW - Taiwan 43
PT - Portogallo 33
PK - Pakistan 31
RO - Romania 29
AU - Australia 27
EC - Ecuador 25
BG - Bulgaria 24
CO - Colombia 22
UZ - Uzbekistan 22
CH - Svizzera 21
GR - Grecia 21
CZ - Repubblica Ceca 20
LT - Lituania 20
VE - Venezuela 20
IL - Israele 19
CL - Cile 18
PY - Paraguay 18
MY - Malesia 15
SA - Arabia Saudita 15
EU - Europa 14
JO - Giordania 14
KE - Kenya 14
EG - Egitto 13
MA - Marocco 11
NP - Nepal 11
PE - Perù 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
HU - Ungheria 8
PH - Filippine 7
ET - Etiopia 6
HN - Honduras 6
KZ - Kazakistan 6
OM - Oman 6
AL - Albania 5
BB - Barbados 5
LB - Libano 5
MU - Mauritius 5
TN - Tunisia 5
BO - Bolivia 4
DZ - Algeria 4
JM - Giamaica 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
TH - Thailandia 4
BH - Bahrain 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
MO - Macao, regione amministrativa speciale della Cina 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
YE - Yemen 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
LY - Libia 2
NG - Nigeria 2
Totale 31.163
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.788
Singapore 1.517
Ashburn 1.352
Hong Kong 915
Milan 911
Woodbridge 866
Frankfurt am Main 711
Fairfield 670
Chandler 632
Houston 576
Wilmington 567
Dublin 556
Ho Chi Minh City 507
Hanoi 400
Dearborn 370
Jacksonville 357
Beijing 350
Santa Clara 332
Dallas 331
Seattle 325
New York 303
Cambridge 246
Los Angeles 242
Hefei 194
Princeton 191
Nanjing 165
Jakarta 145
Shanghai 124
Vienna 123
Helsinki 108
São Paulo 94
Buffalo 92
Chicago 92
Toronto 88
Moscow 87
Guangzhou 85
Seoul 85
Kraków 74
Lawrence 72
Munich 70
The Dalles 69
San Diego 63
Altamura 62
Dong Ket 62
Tokyo 62
Warsaw 60
Council Bluffs 59
Ottawa 59
Lachine 58
Nanchang 55
Fremont 53
Rome 51
Brussels 50
Denver 50
London 46
Melzo 46
Haiphong 45
Montreal 43
Nuremberg 43
Wayne 43
Da Nang 42
Hangzhou 42
Johannesburg 41
Ha Long 39
Kunming 39
Chennai 38
Changsha 37
Pune 37
Boardman 36
Boston 35
Monza 35
Phoenix 35
Poplar 35
Orem 34
Stockholm 34
Andover 33
Shenyang 32
Turku 31
Zhengzhou 31
Brooklyn 30
Hebei 30
Atlanta 29
Biên Hòa 29
Hải Dương 29
Mumbai 27
Tianjin 27
Bắc Ninh 26
Kent 26
Nürnberg 26
Thái Nguyên 26
Bologna 25
Grafing 25
Ankara 24
Can Tho 24
Genoa 24
Norwalk 24
Como 23
Ninh Bình 23
Columbus 22
Jiaxing 22
Totale 20.019
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 637
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 587
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 529
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 512
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 474
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases 468
A new approach for glyco-functionalization of collagen-based biomaterials 467
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 462
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 461
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 461
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 460
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 422
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells 420
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 418
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 413
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 406
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 396
Phage-displayed peptides targeting specific tissues and organs 391
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 387
Nanomedicine for the treatment of Alzheimer's disease 381
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 370
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 366
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 360
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 346
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 346
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 344
Enhanced brain targeting of engineered solid lipid nanoparticles 335
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 334
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor 330
Are the nanoparticles friends or foes when inhaled? 325
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 322
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 321
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 313
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 311
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 306
TrkA pathway activation induced by amyloid-beta (Abeta) 302
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 299
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 295
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 286
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 286
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 286
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 285
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 281
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 277
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 277
Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells 274
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 272
Effect of modified collagen on amyloid beta peptide aggregation 271
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 270
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 269
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 267
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 263
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 260
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 255
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 252
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 252
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 252
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 249
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 248
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 244
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 243
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 241
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 240
Enhanced brain targeting of engineered solid lipid nanoparticles 236
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 233
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 233
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 228
Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine 227
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 227
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 220
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 219
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 215
The fantastic voyage of solid lipid nanoparticles from the lung to the brain: non‐invasive tomographic imaging as a feasible refinement process 211
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 210
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 209
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 208
Direct and indirect air pollution effects on synaptic neurotransmission linked to the development of neurodegenerative disease 207
Nanotechnology for neurodegenerative disorders 206
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 206
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 204
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 204
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 203
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 202
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 202
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 200
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 198
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 194
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 192
In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions 191
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 187
Nanotechnology for neurodegenerative disorders 186
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 182
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 179
Applications of Surface Plasmon Resonance (SPR) for the Characterization of Nanoparticles Developed for Biomedical Purposes 179
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 176
Amyposomes: a new nanomedicine for therapy of Alzheimer disease, waiting for clinical trials 175
Design and validation of a microfluidic device for blood-brain barrier monitoring and transport studies 175
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 173
Pulmonary administration of functionalized nanoparticles significantly reduces beta-amyloid in the brain of an Alzheimer’s disease murine model 172
Self-assembled electrical biodetector based on reduced graphene oxide 171
Totale 29.117
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.513
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.950 0 0 0 0 0 277 284 275 278 299 215 322
2021/20222.187 200 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20242.332 64 81 132 161 240 542 410 117 134 55 114 282
2024/20255.643 280 461 393 305 456 370 387 224 618 855 530 764
2025/20268.463 2.445 987 1.230 1.650 1.851 300 0 0 0 0 0 0
Totale 32.102